Author:
Michel Martin C.,Korstanje Cees,Krauwinkel Walter,Kuipers Mirjam
Reference23 articles.
1. Comparison of the treatment regimens of new and existing LUTS/BPH patients in 6 European countries;Farmer;Eur Urol Suppl,2004
2. Vaage S, for the European Tamsulosin Study Group. Tamsulosin, a selective α1C-adrenoceptor antagonist: a randomised, controlled trial in patients with benign prostatic “obstruction” (symptomatic BPH);Abrams;Br J Urol,1995
3. Tamsulosin, the first prostate-selective α1A-adrenoceptor antagonist: a meta-analysis of two randomised, placebo-controlled, multi-centre studies in patients with benign prostatic obstruction (symptomatic BPH);Chapple;Eur Urol,1996
4. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia;Lepor;Urology,1998
5. Long-term evaluation of tamsulosin in benign prostatic hyperplasia. Placebo-controlled, double-blind extension of phase III trial;Lepor;Urology,1998
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献